Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Burkitt Lymphoma 8Multiple Myeloma 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Biphenotypic, Acute 3Down Syndrome 2Vomiting 1Smoldering Multiple Myeloma 1Opsoclonus-Myoclonus Syndrome 1Neuroblastoma 1Nausea 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Congenital Abnormalities 1Breast Neoplasms 1

Interventions

Cytarabine 5Daunorubicin 4Observation 2Gemtuzumab 2Etoposide 2valspodar 1midostaurin 1laromustine 1etoposide phosphate 1dexamethasone acetate 1aldesleukin 1Watchful Waiting 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Asparaginase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Basophilic, Acute × dexamethasone acetate × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡